Maryland life sciences and biotechnology companies have been at the forefront of the state’s public health response and economic recovery from the COVID-19 pandemic. However, lawmakers are considering policies that weaken the very backbone of Maryland’s robust innovation economy at a time where protecting this industry had never been more critical. Without the necessary policies and protections in place, essential innovation and research, such as COVID-19 clinical trials and cybersecurity development taking place right here in Maryland, could be forced to come to a screeching halt.
Intellectual property (IP) is a critical asset for innovation, research, and development across sectors. IP rights, including copyrights and patents, help defend original works and new inventions, ensuring that a company’s product is distinguishable from others.
Maryland is a hub for growth and innovation across numerous sectors and home to over…
